<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:08:06Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:6080766" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:6080766</identifier><datestamp>2019-02-02</datestamp><setSpec>ajhg</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Am J Hum Genet</journal-id>
      <journal-id journal-id-type="iso-abbrev">Am. J. Hum. Genet</journal-id>
      <journal-title-group>
        <journal-title>American Journal of Human Genetics</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0002-9297</issn>
      <issn pub-type="epub">1537-6605</issn>
      <publisher>
        <publisher-name>Elsevier</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC6080766</article-id>
      <article-id pub-id-type="pmcid">PMC6080766</article-id>
      <article-id pub-id-type="pmc-uid">6080766</article-id>
      <article-id pub-id-type="pmid">30057030</article-id>
      <article-id pub-id-type="publisher-id">S0002-9297(18)30228-3</article-id>
      <article-id pub-id-type="doi">10.1016/j.ajhg.2018.07.001</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Mutations in <italic>TOP3A</italic> Cause a Bloom Syndrome-like Disorder</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Martin</surname>
            <given-names>Carol-Anne</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="fn1" ref-type="fn">26</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>SarlÃ³s</surname>
            <given-names>Kata</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="fn1" ref-type="fn">26</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Logan</surname>
            <given-names>Clare V.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="fn1" ref-type="fn">26</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Thakur</surname>
            <given-names>Roshan Singh</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="fn1" ref-type="fn">26</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Parry</surname>
            <given-names>David A.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bizard</surname>
            <given-names>Anna H.</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Leitch</surname>
            <given-names>Andrea</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cleal</surname>
            <given-names>Louise</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ali</surname>
            <given-names>Nadia Shaukat</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Al-Owain</surname>
            <given-names>Mohammed A.</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Allen</surname>
            <given-names>William</given-names>
          </name>
          <xref rid="aff5" ref-type="aff">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>AltmÃ¼ller</surname>
            <given-names>Janine</given-names>
          </name>
          <xref rid="aff6" ref-type="aff">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aza-Carmona</surname>
            <given-names>Miriam</given-names>
          </name>
          <xref rid="aff7" ref-type="aff">7</xref>
          <xref rid="aff8" ref-type="aff">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barakat</surname>
            <given-names>Bushra A.Y.</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barraza-GarcÃ­a</surname>
            <given-names>Jimena</given-names>
          </name>
          <xref rid="aff7" ref-type="aff">7</xref>
          <xref rid="aff8" ref-type="aff">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Begtrup</surname>
            <given-names>Amber</given-names>
          </name>
          <xref rid="aff9" ref-type="aff">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bogliolo</surname>
            <given-names>Massimo</given-names>
          </name>
          <xref rid="aff8" ref-type="aff">8</xref>
          <xref rid="aff10" ref-type="aff">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cho</surname>
            <given-names>Megan T.</given-names>
          </name>
          <xref rid="aff9" ref-type="aff">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cruz-Rojo</surname>
            <given-names>Jaime</given-names>
          </name>
          <xref rid="aff11" ref-type="aff">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dhahrabi</surname>
            <given-names>Hassan Ali Mundi</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Elcioglu</surname>
            <given-names>Nursel H.</given-names>
          </name>
          <xref rid="aff12" ref-type="aff">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <collab>GOSgene</collab>
          <xref rid="aff13" ref-type="aff">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gorman</surname>
            <given-names>GrÃ¡inne S.</given-names>
          </name>
          <xref rid="aff14" ref-type="aff">14</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jobling</surname>
            <given-names>Rebekah</given-names>
          </name>
          <xref rid="aff15" ref-type="aff">15</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kesterton</surname>
            <given-names>Ian</given-names>
          </name>
          <xref rid="aff16" ref-type="aff">16</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kishita</surname>
            <given-names>Yoshihito</given-names>
          </name>
          <xref rid="aff17" ref-type="aff">17</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kohda</surname>
            <given-names>Masakazu</given-names>
          </name>
          <xref rid="aff17" ref-type="aff">17</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Le Quesne Stabej</surname>
            <given-names>Polona</given-names>
          </name>
          <xref rid="aff13" ref-type="aff">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Malallah</surname>
            <given-names>Asam Jassim</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>NÃ¼rnberg</surname>
            <given-names>Peter</given-names>
          </name>
          <xref rid="aff6" ref-type="aff">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ohtake</surname>
            <given-names>Akira</given-names>
          </name>
          <xref rid="aff18" ref-type="aff">18</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Okazaki</surname>
            <given-names>Yasushi</given-names>
          </name>
          <xref rid="aff17" ref-type="aff">17</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pujol</surname>
            <given-names>Roser</given-names>
          </name>
          <xref rid="aff8" ref-type="aff">8</xref>
          <xref rid="aff10" ref-type="aff">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ramirez</surname>
            <given-names>Maria JosÃ©</given-names>
          </name>
          <xref rid="aff8" ref-type="aff">8</xref>
          <xref rid="aff10" ref-type="aff">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Revah-Politi</surname>
            <given-names>Anya</given-names>
          </name>
          <xref rid="aff19" ref-type="aff">19</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shimura</surname>
            <given-names>Masaru</given-names>
          </name>
          <xref rid="aff20" ref-type="aff">20</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Stevens</surname>
            <given-names>Paul</given-names>
          </name>
          <xref rid="aff16" ref-type="aff">16</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Taylor</surname>
            <given-names>Robert W.</given-names>
          </name>
          <xref rid="aff14" ref-type="aff">14</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Turner</surname>
            <given-names>Lesley</given-names>
          </name>
          <xref rid="aff21" ref-type="aff">21</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Williams</surname>
            <given-names>Hywel</given-names>
          </name>
          <xref rid="aff13" ref-type="aff">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wilson</surname>
            <given-names>Carolyn</given-names>
          </name>
          <xref rid="aff5" ref-type="aff">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yigit</surname>
            <given-names>GÃ¶khan</given-names>
          </name>
          <xref rid="aff22" ref-type="aff">22</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zahavich</surname>
            <given-names>Laura</given-names>
          </name>
          <xref rid="aff15" ref-type="aff">15</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alkuraya</surname>
            <given-names>Fowzan S.</given-names>
          </name>
          <xref rid="aff23" ref-type="aff">23</xref>
          <xref rid="fn2" ref-type="fn">27</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Surralles</surname>
            <given-names>Jordi</given-names>
          </name>
          <xref rid="aff8" ref-type="aff">8</xref>
          <xref rid="aff10" ref-type="aff">10</xref>
          <xref rid="aff24" ref-type="aff">24</xref>
          <xref rid="fn2" ref-type="fn">27</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Iglesais</surname>
            <given-names>Alejandro</given-names>
          </name>
          <xref rid="aff25" ref-type="aff">25</xref>
          <xref rid="fn2" ref-type="fn">27</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Murayama</surname>
            <given-names>Kei</given-names>
          </name>
          <xref rid="aff20" ref-type="aff">20</xref>
          <xref rid="fn2" ref-type="fn">27</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wollnik</surname>
            <given-names>Bernd</given-names>
          </name>
          <xref rid="aff22" ref-type="aff">22</xref>
          <xref rid="fn2" ref-type="fn">27</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dattani</surname>
            <given-names>Mehul</given-names>
          </name>
          <xref rid="aff13" ref-type="aff">13</xref>
          <xref rid="fn2" ref-type="fn">27</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Heath</surname>
            <given-names>Karen E.</given-names>
          </name>
          <xref rid="aff7" ref-type="aff">7</xref>
          <xref rid="aff8" ref-type="aff">8</xref>
          <xref rid="fn2" ref-type="fn">27</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hickson</surname>
            <given-names>Ian D.</given-names>
          </name>
          <email>iandh@sund.ku.dk</email>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="cor1" ref-type="corresp">â</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jackson</surname>
            <given-names>Andrew P.</given-names>
          </name>
          <email>andrew.jackson@igmm.ed.ac.uk</email>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="cor2" ref-type="corresp">ââ</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK</aff>
      <aff id="aff2"><label>2</label>Center for Chromosome Stability and Center for Healthy Aging, Department of Cellular and Molecular Medicine, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen N, Denmark</aff>
      <aff id="aff3"><label>3</label>Dubai Hospital, Al Khaleej Street, Al Baraha, PO Box 7272, Dubai</aff>
      <aff id="aff4"><label>4</label>Department of Medical Genetics, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi Arabia</aff>
      <aff id="aff5"><label>5</label>Fullerton Genetics Center, Asheville, NC 28803, USA</aff>
      <aff id="aff6"><label>6</label>Cologne Center for Genomics, University of Cologne, 50931 Cologne, Germany</aff>
      <aff id="aff7"><label>7</label>Institute of Medical and Molecular Genetics and Skeletal dysplasia multidisciplinary Unit, Hospital Universitario La Paz, Universidad AutÃ³noma de Madrid, IdiPaz, Madrid 28046, Spain</aff>
      <aff id="aff8"><label>8</label>Centro de InvestigaciÃ³n BiomÃ©dica en Red de Enfermedades Raras, Madrid 28029, Spain</aff>
      <aff id="aff9"><label>9</label>GeneDx, 207 Perry Parkway, Gaithersburg, MD 20877, USA</aff>
      <aff id="aff10"><label>10</label>Department of Genetics and Microbiology, Universitat AutÃ²noma de Barcelona, Bellaterra 08193, Spain</aff>
      <aff id="aff11"><label>11</label>Department of Pediatric Endocrinology &amp; Dysmorphology, Hospital 12 Octubre, Madrid 28041, Spain</aff>
      <aff id="aff12"><label>12</label>Department of Pediatric Genetics, Marmara University Medical School, Istanbul 34722, Turkey</aff>
      <aff id="aff13"><label>13</label>UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK</aff>
      <aff id="aff14"><label>14</label>Wellcome Centre for Mitochondrial Research, Institute of Neuroscience, School of Medical Education, Newcastle University, Newcastle upon Tyne NE2 4HH, UK</aff>
      <aff id="aff15"><label>15</label>The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada</aff>
      <aff id="aff16"><label>16</label>Cytogenetics Department, Viapath Analytics, Guyâs Hospital, London SE1 9RT, UK</aff>
      <aff id="aff17"><label>17</label>Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan</aff>
      <aff id="aff18"><label>18</label>Department of Pediatrics, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama, Saitama 350-0495, Japan</aff>
      <aff id="aff19"><label>19</label>Institute for Genomic Medicine, Columbia University Medical Center, New York, NY 10032, USA</aff>
      <aff id="aff20"><label>20</label>Center for Medical Genetics, Department of Metabolism, Chiba Childrenâs Hospital, 579-1, Heta-cho, Midori-ku, Chiba 266-0007, Japan</aff>
      <aff id="aff21"><label>21</label>Memorial University of Newfoundland, St. Johnâs, NL A1C 5S7, Canada</aff>
      <aff id="aff22"><label>22</label>Institute of Human Genetics, University Medical Center GÃ¶ttingen, 37073 GÃ¶ttingen, Germany</aff>
      <aff id="aff23"><label>23</label>Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi Arabia</aff>
      <aff id="aff24"><label>24</label>Department of Genetics and Biomedical Research Institute Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona 08041, Spain</aff>
      <aff id="aff25"><label>25</label>Department of Pediatrics, Division of Clinical Genetics, Columbia University Medical Center, New York, NY 10032, USA</aff>
      <author-notes>
        <corresp id="cor1"><label>â</label>Corresponding author <email>iandh@sund.ku.dk</email></corresp>
        <corresp id="cor2"><label>ââ</label>Corresponding author <email>andrew.jackson@igmm.ed.ac.uk</email></corresp>
        <fn id="fn1">
          <label>26</label>
          <p id="ntpara0010">These authors contributed equally to this work</p>
        </fn>
        <fn id="fn2">
          <label>27</label>
          <p id="ntpara0015">These authors contributed equally to this work</p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>02</day>
        <month>8</month>
        <year>2018</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>26</day>
        <month>7</month>
        <year>2018</year>
      </pub-date>
      <volume>103</volume>
      <issue>2</issue>
      <fpage>221</fpage>
      <lpage>231</lpage>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>4</month>
          <year>2018</year>
        </date>
        <date date-type="accepted">
          <day>29</day>
          <month>6</month>
          <year>2018</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© 2018 The Authors</copyright-statement>
        <copyright-year>2018</copyright-year>
        <license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">
          <license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p>
        </license>
      </permissions>
      <abstract id="abs0010">
        <p>Bloom syndrome, caused by biallelic mutations in <italic>BLM</italic>, is characterized by prenatal-onset growth deficiency, short stature, an erythematous photosensitive malar rash, and increased cancer predisposition. Diagnostically, a hallmark feature is the presence of increased sister chromatid exchanges (SCEs) on cytogenetic testing. Here, we describe biallelic mutations in <italic>TOP3A</italic> in ten individuals with prenatal-onset growth restriction and microcephaly. <italic>TOP3A</italic> encodes topoisomerase III alpha (TopIIIÎ±), which binds to BLM as part of the BTRR complex, and promotes dissolution of double Holliday junctions arising during homologous recombination. We also identify a homozygous truncating variant in <italic>RMI1</italic>, which encodes another component of the BTRR complex, in two individuals with microcephalic dwarfism. The <italic>TOP3A</italic> mutations substantially reduce cellular levels of TopIIIÎ±, and consequently subjectsâ cells demonstrate elevated rates of SCE. Unresolved DNA recombination and/or replication intermediates persist into mitosis, leading to chromosome segregation defects and genome instability that most likely explain the growth restriction seen in these subjects and in Bloom syndrome. Clinical features of mitochondrial dysfunction are evident in several individuals with biallelic <italic>TOP3A</italic> mutations, consistent with the recently reported additional function of TopIIIÎ± in mitochondrial DNA decatenation. In summary, our findings establish <italic>TOP3A</italic> mutations as an additional cause of prenatal-onset short stature with increased cytogenetic SCEs and implicate the decatenation activity of the BTRR complex in their pathogenesis.</p>
      </abstract>
      <kwd-group id="kwrds0010">
        <title>Keywords</title>
        <kwd>topoisomerase III</kwd>
        <kwd>RecQ helicases</kwd>
        <kwd>BLM</kwd>
        <kwd>genomic instability</kwd>
        <kwd>double Holliday junction dissolution</kwd>
        <kwd>Bloom syndrome</kwd>
      </kwd-group>
    </article-meta>
    <notes>
      <p id="misc0010">Published: July 26, 2018</p>
    </notes>
  </front>
  <body>
    <sec id="sec1">
      <title>Introduction</title>
      <p id="p0010">Microcephalic primordial dwarfism (MPD) is used toÂ collectively describe a heterogeneous group of disordersÂ characterized by significant in utero and postnatal growth retardation alongside marked microcephaly.<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref> Bloom syndrome (MIM: <ext-link ext-link-type="omim" xlink:href="210900" id="intref0010">210900</ext-link>) is also associated with prenatal growth restriction, short stature, andÂ microcephaly. It is distinguished by an erythematous sun-sensitive facial rash that can become evident duringÂ childhood.<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> A predisposition to the development of cancer in early adulthood is also seen, and both solidÂ tumors and hematological malignancies are a majorÂ cause of early death.<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> Additionally, a key cytogenetic feature of Bloom syndrome is an increased number of sister chromatid exchanges (SCEs).<xref rid="bib4" ref-type="bibr"><sup>4</sup></xref> Notably, when molecular testing is inconclusive, a finding of elevated SCEs is currently utilized for diagnostic confirmationÂ ofÂ Bloom syndrome (see GeneReviews in <xref rid="app3" ref-type="sec">Web Resources</xref>).</p>
      <p id="p0015">In 1995, Bloom syndrome was shown to be caused by mutations in <italic>BLM</italic> (MIM: <ext-link ext-link-type="omim" xlink:href="604610" id="intref0015">604610</ext-link>), which encodes a RecQ family DNA helicase.<xref rid="bib5" ref-type="bibr"><sup>5</sup></xref> Mutations in <italic>BLM</italic> are typically biallelic loss-of-function mutations.<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref> BLM forms the BTRR complex with topoisomerase III alpha (TopIIIÎ±) and RecQ-mediated genome instability proteins 1 and 2 (RMI1 and RMI2, respectively). Together, these proteins process double Holliday junctions (dHJs) that arise as a result of homologous-recombination-mediated repair of double-stranded DNA (dsDNA) breaks during DNA synthesis.<xref rid="bib7" ref-type="bibr">7</xref>, <xref rid="bib8" ref-type="bibr">8</xref>, <xref rid="bib9" ref-type="bibr">9</xref>, <xref rid="bib10" ref-type="bibr">10</xref>, <xref rid="bib11" ref-type="bibr">11</xref>, <xref rid="bib12" ref-type="bibr">12</xref>, <xref rid="bib13" ref-type="bibr">13</xref> The process of dHJ dissolution requires two steps. First, the BTRR complex promotes the convergent branch migration of the dHJ to create a hemicatenane intermediate, and then this structure is decatenated by TopIIIÎ± in concert with RMI1 and RMI2.<xref rid="bib14" ref-type="bibr">14</xref>, <xref rid="bib15" ref-type="bibr">15</xref> Dissolution of a dHJ by this mechanism can be completed without any potentially detrimental exchanges between genetic markers flanking the original site of homologous recombination. The alternative processing of dHJs by Holliday junction resolvases (SLX-MUS81 and GEN1 nucleases) can yield crossover events, and increased usage of this pathway hasÂ been proposed to explain the increase in SCEs in BLM-deficient cells.<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref> Crossover events between homologous chromosomes can lead to loss of heterozygosity (LOH),<xref rid="bib17" ref-type="bibr"><sup>17</sup></xref> which can be detrimental to cell survival and contribute to increased cancer predisposition.<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref> Additionally, unresolved recombination intermediates can persist into mitosis, leading to chromosome bridges, and act as a source of genome instability.<xref rid="bib19" ref-type="bibr"><sup>19</sup></xref></p>
      <p id="p0020">Here, we report the identification of pathogenic mutations in <italic>TOP3A</italic> (MIM: <ext-link ext-link-type="omim" xlink:href="601243" id="intref0020">601243</ext-link>) in ten individuals with Bloom syndrome-like phenotypic features and characterize the cellular consequences of these mutations.</p>
    </sec>
    <sec id="sec2">
      <title>Material and Methods</title>
      <sec id="sec2.1">
        <title>Research Subjects</title>
        <p id="p0025">Genomic DNA from the affected individuals and family members was extracted from peripheral blood by standard methods or obtained from saliva samples with Oragene collection kits according to the manufacturerâs instructions. Informed consent was obtained from all participating families, and all procedures performed in studies involving human participants were in accordance with the Declaration of Helsinki. Research studies were approved by the Scottish Multicenter Research Ethics Committee (05/MRE00/74), the Hospital Universitario La Paz Ethical Committee (PI-2630), the Great Ormond Street Hospital Research Ethics Committee (09/H0706/66), the University Medical Center GÃ¶ttingen Ethics Committee (vote ref. 3/2/1), and the Institute for Genomic Medicine at Columbia University (protocol AAAO8410).</p>
        <p id="p0030">Parents provided written consent for the publication of photographs of the affected individuals. For growth measurements, <italic>Z</italic> scores (standard deviations from population mean for age and sex) were calculated according to LMS (L, smooth curve;Â M, median; S, coefficient of variation) growth on the basis of British 1990 growth reference data.<xref rid="bib20" ref-type="bibr"><sup>20</sup></xref> For calculation of <italic>Z</italic> scores for growth measurements published for Bloom syndrome,<xref rid="bib21" ref-type="bibr"><sup>21</sup></xref> full-term gestation was assumed, and postnatal growth measurements were calculated from data provided for the 18- to 21-year age range.</p>
      </sec>
      <sec id="sec2.2">
        <title>Exome Sequencing and Sanger Sequencing</title>
        <p id="p0035">Exome sequencing and confirmatory capillary Sanger sequencing were performed according to standard methodologies as previously published.<xref rid="bib22" ref-type="bibr">22</xref>, <xref rid="bib23" ref-type="bibr">23</xref> TOP3A and RMI1 variants were annotated with GenBank: <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_004618.4" id="intref0025">NM_004618.4</ext-link> and <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_024945.2" id="intref0030">NM_024945.2</ext-link> reference sequences, respectively.</p>
      </sec>
      <sec id="sec2.3">
        <title>Plasmid Construct and Protein Purification</title>
        <sec id="sec2.3.1">
          <title>Cloning of the Mutant hTopIIIÎ± Expression Vector</title>
          <p id="p0040">A plasmid encoding the wild-type (WT) <italic>TOP3A</italic> cDNA<xref rid="bib24" ref-type="bibr"><sup>24</sup></xref> was modified by the Quickchange XL Site-Directed Mutagenesis Kit (Agilent technologies) with the following primers to recapitulate the deletion and frameshift present in subject P1: 5â²-CCCTCCGTCACACGACTGTGCAGAAGGA-3â² (T3_FS_FW) and 5â²-TCCTTCTGCACAGTCGTGTGACGGAGGG-3â² (T3_FS_RW).</p>
        </sec>
        <sec id="sec2.3.2">
          <title>Expression and Purification of TRR</title>
          <p id="p0045">The previously described plasmids encoding RMI1 and RMI2<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref> and hTopoIIIÎ±<xref rid="bib24" ref-type="bibr"><sup>24</sup></xref> were co-transformed into <italic>E.Â coli</italic> Rosetta 2 cells, and the complex was expressed. The cells were disrupted in buffer A (50Â mM Tris-HCl [pH 7.5], 0.5Â M NaCl, 10% glycerol, 0.1% IGEPAL, 2Â mM Î²-mercaptoethanol, 40Â mM imidazole, 1Â mM PMSF, and protease inhibitor tablet [PI, EDTA-free, Roche]) on ice before dounce homogenization and sonication. After the removal of cell debris by centrifugation, the lysate was affinity purified on a 5Â mL HisTrap HP affinity column. The complex was further purified on a 5Â mL HiTrap Heparin HP column in buffer B (50Â mM Tris-HCl [pH 7.5], 10% glycerol, 0.1Â mM EDTA, and 1Â mM DTT) with a linear gradient of 200Â mM to 1Â M NaCl and then gel filtered on a 120Â mL HiLoad 16/600 Superdex 200 column in buffer B containing 200Â mM NaCl. Expression and purification of the mutant T<sup>Thr812LeufsTer101</sup>RR complex were performed in a similar manner. BLM was purified as described previously.<xref rid="bib25" ref-type="bibr">25</xref>, <xref rid="bib26" ref-type="bibr">26</xref></p>
        </sec>
        <sec id="sec2.3.3">
          <title>dHJ Dissolution</title>
          <p id="p0050">The dHJ substrate construction and dissolution reactions were carried out as described previously.<xref rid="bib14" ref-type="bibr"><sup>14</sup></xref></p>
        </sec>
      </sec>
      <sec id="sec2.4">
        <title>Cell Culture</title>
        <p id="p0055">Dermal fibroblasts were obtained by skin-punch biopsy and wereÂ maintained in amnioMAX C-100 complete medium (Life Technologies) in a 37Â°C incubator with 5% CO<sub>2</sub> and 3% O<sub>2</sub>. siRNA oligonucleotides (siLUC: 5â²-CUUACGCUGAGUACUUCGA-3â² [siTopIIIÎ± SMARTpool M-005279-01-0005, Dharmacon]) were transfected into dermal fibroblasts with RNAiMAX (Life Technologies) according to the manufacturerâs instructions.</p>
      </sec>
      <sec id="sec2.5">
        <title>Sister Chromatid Exchange Assay</title>
        <p id="p0060">Dermal fibroblasts were treated with 10Â Î¼M BrdU for 48Â hr followed by 0.5Â Î¼g/mL colcemid for 2Â hr. Metaphases and nuclei were isolated in hypotonic buffer (0.25% KCl and 1% Na<sub>3</sub>C<sub>6</sub>H<sub>5</sub>O<sub>7</sub>), fixed with methanol and acetic acid (3:1 vol/vol), and dropped onto slides. Dried slides were rehydrated in PBS and then incubated with 2Â Î¼g/mL Hoescht 33342 stain in 2Ã saline sodium citrate (SSC) buffer (300Â mM NaCl and 30Â mM sodium citrate) for 15Â min. Slides were then covered in 2Ã SSC buffer, irradiated in ultraviolet A at 5,400 J/m<sup>2</sup>, dehydrated in an ethanol series, and mounted in VECTASHIELD with DAPI.</p>
        <sec id="sec2.5.1">
          <title>SCE Methodology for Analysis of P7 and P8</title>
          <p id="p0065">Dermal fibroblasts were treated with 26.05Â Î¼M BrdU for 72Â hr followed by 0.5Â Î¼g/mL colcemid for 5Â hr and then harvested. Cells were resuspended in a pre-warmed hypotonic solution (0.051Â M KCl) for 20Â min at 37Â°C, fixed with methanol and acetic acid (3:1 vol/vol), and dropped onto slides. Samples were aged for at least 3Â days and then stained with 1.56Â Î¼g/mL Hoechst 33258 (Sigma, B2883). Slides were irradiated in 2Ã SSC with ultraviolet C (356Â nm) at 0.260 J/cm<sup>2</sup>, washed with 2Ã SSC, and stained with 10% Giemsa in phosphate buffer.</p>
          <p id="p0070">SCE analysis of peripheral-blood samples was performed according to standard methodology in a diagnostic lab setting.<xref rid="bib27" ref-type="bibr"><sup>27</sup></xref></p>
        </sec>
      </sec>
      <sec id="sec2.6">
        <title>Immunofluorescence and microscopy</title>
        <p id="p0075">Mitotic abnormalities and G1-associated defects were analyzed as described previously.<xref rid="bib28" ref-type="bibr">28</xref>, <xref rid="bib29" ref-type="bibr">29</xref> In brief, for mitotic analysis, cells were seeded onto 22Â Ã 22Â mm glass coverslips in 6-well plates. After 18Â hr, cells were treated with 3.5Â Î¼M RO3306 for 6Â hr for the induction of a late G2 arrest and were subsequently released into fresh media. After 45Â min, cells were fixed with 4% paraformaldehyde containing 0.2% Triton X-100 in PBS for 20Â min. For G1-associated defects, RO3306-treated cells were released into fresh media for 30Â min. Prometaphase cells were shaken off and re-seeded onto glass slides coated with poly-<sc>l</sc>-lysine. After 4â6Â hr, cells were fixed with 4% paraformaldehyde for 10Â min and permeabilized with 0.5% Triton X-100 for 10Â min. Fixed cells were incubated with antibodies specific to cyclin A (Santa Cruz Biotechnology, sc-596), 53BP1 (Santa Cruz Biotechnology, sc-515841), and PICH.<xref rid="bib30" ref-type="bibr"><sup>30</sup></xref></p>
      </sec>
      <sec id="sec2.7">
        <title>Immunoblotting</title>
        <p id="p0080">Cells were lysed in 50Â mM Tris-HCl (pH 8), 280Â mM NaCl, 0.5% NP40, 0.2Â mM EDTA, 0.2Â mM EGTA, and 10% glycerol supplemented with a protease inhibitor tablet (Roche Life Science). Protein samples were run on a 4%â12% NuPAGE Bis-Tris precast gel (Life Technologies) and then immunoblotted with anti-TopIIIÎ± raised against amino acids 652â1,001 (Proteintech, 14525-1-AP) and actin (Sigma, A2066).</p>
      </sec>
    </sec>
    <sec id="sec3">
      <title>Results</title>
      <sec id="sec3.1">
        <title>Identification of Mutations in <italic>TOP3A</italic></title>
        <p id="p0085">In ongoing work to identify genes associated with microcephalic dwarfism, whole-exome sequencing (WES) was performed on subject P1, who had significant microcephaly and short stature (â5.7 and â4.4 standard deviations [SD], respectively). This identified the homozygous frameshift mutation c.2718del (p.Thr907LeufsTer101) (GenBank: <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_004618.4" id="intref0035">NM_004618.4</ext-link>) in <italic>TOP3A</italic> in chromosomal region 17p11.2. After interrogation of other cohorts and clinical contacts made through GeneMatcher,<xref rid="bib31" ref-type="bibr"><sup>31</sup></xref> we subsequently ascertained a further nine individuals from seven families affected by biallelic deleterious <italic>TOP3A</italic> variants that had also been discovered by WES (<xref rid="tbl1" ref-type="table">Table 1</xref>). All variants identified were validated by Sanger capillary sequencing, and all parents were confirmed to be heterozygous carriers. Aside from the c.2718del variant (minor allele frequency = 0.00041%), none of the other variants were reported in GnomAD.<xref rid="bib33" ref-type="bibr"><sup>33</sup></xref> Notably, four of the families from the United Arab Emirates, Syria, and Saudi Arabia (F2, F4, F6, and F7), were homozygous for the same variant.<table-wrap id="tbl1" position="float"><label>Table 1</label><caption><p>Identified <italic>TOP3A</italic> and <italic>RMI1</italic> Variants Associated with Microcephalic Dwarfism</p></caption><table frame="hsides" rules="groups"><thead><tr><th><bold>Family</bold></th><th><bold>Individual</bold></th><th><bold>Gene</bold></th><th><bold>Biallelic Nucleotide Mutations</bold></th><th><bold>Predicted Amino Acid Consequence(s)</bold></th><th><bold>Sex</bold></th><th><bold>Country of Origin</bold></th></tr></thead><tbody><tr><td>1</td><td>P1</td><td><italic>TOP3A</italic></td><td>c.[2718del];[2718del]</td><td>p.[Thr907LeufsTer101];[Thr907LeufsTer101]</td><td>female</td><td>USA (Czech and Irish ancestry)</td></tr><tr><td rowspan="3">2</td><td>P2</td><td><italic>TOP3A</italic></td><td>c.[2271dup];[2271dup]</td><td>p.[Arg758GlnfsTer3];[Arg758GlnfsTer3]</td><td>female</td><td>United Arab Emirates</td></tr><tr><td>P3</td><td><italic>TOP3A</italic></td><td>c.[2271dup];[2271dup]</td><td>p.[Arg758GlnfsTer3];[Arg758GlnfsTer3]</td><td>female</td><td>United Arab Emirates</td></tr><tr><td>P4</td><td><italic>TOP3A</italic></td><td>c.[2271dup];[2271dup]</td><td>p.[Arg758GlnfsTer3];[Arg758GlnfsTer3]</td><td>male</td><td>United Arab Emirates</td></tr><tr><td>3</td><td>P5</td><td><italic>TOP3A</italic></td><td>c.[527C&gt;T];[1072_1073dup]<xref rid="tblfn1" ref-type="table-fn">a</xref></td><td>p.[Ala176Val];[Tyr359GlyfsTer17]</td><td>female</td><td>Japan</td></tr><tr><td>4</td><td>P6</td><td><italic>TOP3A</italic></td><td>c.[2271dup];[2271dup]</td><td>p.[Arg758GlnfsTer3];[Arg758GlnfsTer3]</td><td>female</td><td>Syria</td></tr><tr><td rowspan="2">5</td><td>P7</td><td><italic>TOP3A</italic></td><td>c.[2428del];[2428del]</td><td>p.[Ser810LeufsTer2];[Ser810LeufsTer2]</td><td>female</td><td>Spain</td></tr><tr><td>P8</td><td><italic>TOP3A</italic></td><td>c.[2428del];[2428del]</td><td>p.[Ser810LeufsTer2];[Ser810LeufsTer2]</td><td>male</td><td>Spain</td></tr><tr><td>6</td><td>P9</td><td><italic>TOP3A</italic></td><td>c.[2771dup];[2771dup]</td><td>p.[Arg758GlnfsTer3];[Arg758GlnfsTer3]</td><td>male</td><td>Syria</td></tr><tr><td>7</td><td>P10</td><td><italic>TOP3A</italic></td><td>c.[2771dup];[2771dup]</td><td>p.[Arg758GlnfsTer3];[Arg758GlnfsTer3]</td><td>female</td><td>Saudi Arabia</td></tr><tr><td rowspan="2">8</td><td>P11</td><td><italic>RMI1</italic></td><td>c.[1255_1259del];[1255_1259del]</td><td>p.[Lys419LeufsTer5]; [Lys419LeufsTer5]</td><td>female</td><td>Turkey</td></tr><tr><td>P12</td><td><italic>RMI1</italic></td><td>c.[1255_1259del];[1255_1259del]</td><td>p.[Lys419LeufsTer5];[Lys419LeufsTer5]</td><td>female</td><td>Turkey</td></tr><tr><td>â</td><td>MC1<xref rid="tblfn2" ref-type="table-fn">b</xref></td><td><italic>TOP3A</italic></td><td>c.[298A&gt;G];[403C&gt;T]</td><td>p.[Met100Val];[Arg135Ter]</td><td>female</td><td>UK</td></tr></tbody></table><table-wrap-foot><fn><p>Nomenclature is according to transcript GenBank: <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_004618.4" id="intref0065">NM_004618.4</ext-link> for <italic>TOP3A</italic> and GenBank: <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_004618.4" id="intref0070">NM_004618.4</ext-link> and <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_024945.2" id="intref0075">NM_024945.2</ext-link> for <italic>RMI1</italic>.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn1"><label>a</label><p id="ntpara0020">Close to donor splice site of exon 10.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn2"><label>b</label><p id="ntpara0025">Previously reported individual with adult-onset mitochondrial disease.<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref></p></fn></table-wrap-foot></table-wrap></p>
      </sec>
      <sec id="sec3.2">
        <title>Prenatal-Onset Growth Restriction and Microcephaly in Individuals with <italic>TOP3A</italic> Mutations</title>
        <p id="p0090">Prenatal growth restriction was evident from the substantially reduced birth weight in all individuals (mean weight â2.6 Â± 0.9 SD; <xref rid="tbl2" ref-type="table">Table 2</xref> and <xref rid="fig1" ref-type="fig">FigureÂ 1</xref>A). Postnatally, weight (mean â4.8 Â± 1.8 SD), height (mean â3.9 Â± 1.0 SD), and occipital-frontal circumference (mean â4.0 Â± 1.2 SD) were significantly reduced. Growth parameters were similar to those previously reported for Bloom syndrome (mean birth weight â3.7 Â± 1.2 SD, mean postnatal weight â3.8 Â± 2.1 SD, and mean height â3.9 Â± 1.1 SD).<xref rid="bib21" ref-type="bibr"><sup>21</sup></xref> Although multiple cafÃ©-au-lait patches were present in some individuals with <italic>TOP3A</italic> mutations, the classical erythematous malar facial rash was not apparent, and there were no reports of malignancies (although none had yet reached adulthood; <xref rid="tbl3" ref-type="table">Table 3</xref> and <xref rid="fig1" ref-type="fig">FigureÂ 1</xref>B).<fig id="fig1"><label>FigureÂ 1</label><caption><p>Variants in <italic>TOP3A</italic> Are Associated with Prenatal-Onset Growth Retardation and Microcephaly</p><p>(A) Morphometric data for <italic>TOP3A</italic> individuals. A global reduction in growth is evident from before birth. <italic>Z</italic> scores (standard deviations from population mean for age and sex) for birth weight (Wgt), postnatal weight, height (Hgt), and occipital-frontal circumference (OFC). Dashed lines indicate the 95% confidence interval for the general population. Black circles indicate data points for individuals with <italic>TOP3A</italic> mutations. For comparison, gray bars indicate the mean value for cohorts of 89 (birth weight), 47 (current weight), and 52 (current height) subjects with Bloom syndrome.<xref rid="bib21" ref-type="bibr"><sup>21</sup></xref></p><p>(B) Photographs of facial features of individuals with <italic>TOP3A</italic> mutations.</p></caption><graphic xlink:href="gr1"/></fig><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><p>Growth Parameters of Individuals with <italic>TOP3A</italic> and <italic>RMI1</italic> Mutations</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3"><bold>Individual</bold></th><th rowspan="3"><bold>Mutated Gene</bold></th><th colspan="7"><bold>Birth</bold><hr/></th><th colspan="7"><bold>Postnatal</bold><hr/></th></tr><tr><th rowspan="2"><bold>Gestational Age (Weeks)</bold></th><th colspan="2"><bold>Weight</bold><hr/></th><th colspan="2"><bold>OFC</bold><hr/></th><th colspan="2"><bold>Length</bold><hr/></th><th rowspan="2"><bold>Age at Exam</bold></th><th colspan="2"><bold>Weight</bold><hr/></th><th colspan="2"><bold>OFC</bold><hr/></th><th colspan="2"><bold>Height</bold><hr/></th></tr><tr><th><bold>kg</bold></th><th><bold><italic>Z</italic> Score (SD)</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></th><th><bold>cm</bold></th><th><bold><italic>Z</italic> Score (SD)</bold></th><th><bold>cm</bold></th><th><bold><italic>Z</italic> Score (SD)</bold></th><th><bold>kg</bold></th><th><bold><italic>Z</italic> Score (SD)</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></th><th><bold>cm</bold></th><th><bold><italic>Z</italic> Score (SD)</bold></th><th><bold>cm</bold></th><th><bold><italic>Z</italic> Score (SD)</bold></th></tr></thead><tbody><tr><td>P1</td><td><italic>TOP3A</italic></td><td>37</td><td>1.35</td><td>â3.9</td><td>27.5</td><td>â4.2</td><td>38</td><td>â5.4</td><td>5Â months</td><td>4.9</td><td>â2.7</td><td>36</td><td>â5.7</td><td>54.8</td><td>â4.4</td></tr><tr><td>P2</td><td><italic>TOP3A</italic></td><td>37</td><td>1.9</td><td>â2.3</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>3 years</td><td>9.5</td><td>â3.7</td><td>47.5</td><td>â2.3</td><td>84.5</td><td>â2.8</td></tr><tr><td>P3</td><td><italic>TOP3A</italic></td><td>37</td><td>2.2</td><td>â1.6</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>8 years</td><td>16.5</td><td>â3.3</td><td>49.5</td><td>â2.9</td><td>112.5</td><td>â2.7</td></tr><tr><td>P4</td><td><italic>TOP3A</italic></td><td>40</td><td>2.2</td><td>â2.9</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>10 years</td><td>18.1</td><td>â4.6</td><td>49.5</td><td>â3.1</td><td>113</td><td>â4.1</td></tr><tr><td>P5</td><td><italic>TOP3A</italic></td><td>35</td><td>1.91</td><td>â1.3</td><td>31.8</td><td>â0.2</td><td>43</td><td>â1.8</td><td>15 years</td><td>20</td><td>â6.4</td><td>51</td><td>â3.1</td><td>138</td><td>â3.7</td></tr><tr><td>P6</td><td><italic>TOP3A</italic></td><td>NA</td><td>2</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>19Â months</td><td>5.17</td><td>â7.5</td><td>44.3</td><td>â3.0</td><td>64.3</td><td>â5.8</td></tr><tr><td>P7</td><td><italic>TOP3A</italic></td><td>38</td><td>1.90</td><td>â2.8</td><td>30.0</td><td>â2.7</td><td>41</td><td>â4.1</td><td>3 years, 3Â months</td><td>7.21</td><td>â7.0</td><td>44.2</td><td>â5.3</td><td>78.7</td><td>â4.7</td></tr><tr><td>P8</td><td><italic>TOP3A</italic></td><td>34</td><td>1.41</td><td>â2.5</td><td>28.5</td><td>â2.2</td><td>42</td><td>â2.1</td><td>7 years<xref rid="tblfn4" ref-type="table-fn">b</xref></td><td>10</td><td>â2.9</td><td>45.8</td><td>â5.0</td><td>98.1</td><td>â4.5</td></tr><tr><td>P9</td><td><italic>TOP3A</italic></td><td>40</td><td>2</td><td>â3.4</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>11 years</td><td>21.6</td><td>â3.5</td><td>47.5</td><td>â4.5</td><td>125.6</td><td>â2.7</td></tr><tr><td>P10</td><td><italic>TOP3A</italic></td><td>36</td><td>1.6</td><td>â2.7</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>4 years, 7Â months</td><td>9</td><td>â6.1</td><td>45.5</td><td>â5.0</td><td>91</td><td>â3.3</td></tr><tr><td>P11</td><td><italic>RMI1</italic></td><td>34</td><td>1.59</td><td>â1.7</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>7 years</td><td>14</td><td>â3.8</td><td>46.5</td><td>â5</td><td>100</td><td>â4</td></tr><tr><td>P12</td><td><italic>RMI1</italic></td><td>38</td><td>1.80</td><td>â3.1</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>13 years</td><td>39</td><td>â0.9</td><td>48</td><td>â5</td><td>135</td><td>â2.9</td></tr><tr><td>MC1<xref rid="tblfn5" ref-type="table-fn">c</xref></td><td><italic>TOP3A</italic></td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>adult</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>163</td><td>NA</td></tr></tbody></table><table-wrap-foot><fn><p><italic>Z</italic> scores are the standard deviation from population mean for age and sex. The following abbreviation is used: NA, not available.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn3"><label>a</label><p id="ntpara0030">Adjusted for gestation.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn4"><label>b</label><p id="ntpara0035">Growth-hormone treatment from 4 years, 3Â months of age to 5 years, 11Â months of age showed no response.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn5"><label>c</label><p id="ntpara0040">Previously reported individual with adult-onset mitochondrial disease (ataxia and progressive external ophthalmoplegia).<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref></p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl3" position="float"><label>Table 3</label><caption><p>Clinical Phenotype of Individuals with <italic>TOP3A</italic> and <italic>RMI1</italic> Mutations</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th colspan="11"><bold><italic>TOP3A</italic></bold><hr/></th><th colspan="2"><bold><italic>RMI1</italic></bold><hr/></th></tr><tr><th><bold>P1</bold></th><th><bold>P2</bold></th><th><bold>P3</bold></th><th><bold>P4</bold></th><th><bold>P5</bold></th><th><bold>P6</bold></th><th><bold>P7</bold></th><th><bold>P8</bold></th><th><bold>P9</bold></th><th><bold>P10</bold></th><th><bold>MC1</bold></th><th><bold>P11</bold></th><th><bold>P12</bold></th></tr></thead><tbody><tr><td>Age</td><td>5Â months</td><td>3 years</td><td>8 years</td><td>10 years</td><td>15 years</td><td>19Â months</td><td>3 years</td><td>7 years</td><td>11 years</td><td>4 years, 7Â months</td><td>adult</td><td>7 years</td><td>13 years</td></tr><tr><td>Prenatal-onset growth restriction</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>no</td><td>yes</td><td>yes</td></tr><tr><td>Elevated sister chromatid exchange</td><td>yes</td><td>yes</td><td>yes</td><td>NA</td><td>yes</td><td>NA</td><td>yes</td><td>yes</td><td>yes</td><td>NA</td><td>no</td><td>NA</td><td>NA</td></tr><tr><td>CafÃ©-au-lait macules</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>no</td><td>yes</td><td>no</td><td>yes</td><td>yes</td><td>yes</td><td>NA</td><td>no</td><td>no</td></tr><tr><td>Developmental delay</td><td>mild</td><td>no</td><td>no</td><td>no</td><td>no</td><td>mild<xref rid="tblfn6" ref-type="table-fn">a</xref></td><td>no</td><td>mild</td><td>no</td><td>mild</td><td>NA</td><td>mild</td><td>no</td></tr><tr><td>Cancer<xref rid="tblfn7" ref-type="table-fn">b</xref></td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>NA</td><td>no</td><td>no</td></tr><tr><td>Decreased subcutaneous fat</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>yes</td><td>yes</td><td>no</td><td>yes</td><td>NA</td><td>no</td><td>no</td></tr><tr><td>Gastroesophageal reflux</td><td>yes</td><td>NA</td><td>NA</td><td>NA</td><td>no</td><td>yes</td><td>no</td><td>NA</td><td>no</td><td>NA</td><td>NA</td><td>no</td><td>no</td></tr><tr><td>Diabetes mellitus</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>NA</td><td>no</td><td>no</td></tr><tr><td>Recurrent infections</td><td>yes<xref rid="tblfn8" ref-type="table-fn">c</xref></td><td>NA</td><td>NA</td><td>NA</td><td>no</td><td>no</td><td>no</td><td>NA</td><td>yes</td><td>yes<xref rid="tblfn9" ref-type="table-fn">d</xref></td><td>NA</td><td>no</td><td>no</td></tr><tr><td>Malar rash</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>NA</td><td>no</td><td>no</td></tr><tr><td>Dilated cardiomyopathy</td><td>no</td><td>no</td><td>yes</td><td>yes (severe, deceased)</td><td>yes (after heart transplant)</td><td>normal echocardiogram</td><td>NA</td><td>yes<xref rid="tblfn10" ref-type="table-fn">e</xref> (asymptomatic)</td><td>HCM</td><td>no</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>Mitochondrial DNA depletion in muscle</td><td>NA</td><td>NA</td><td>NA</td><td>N/A</td><td>yes (87%)</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>yes (&gt;80%)</td><td>NA</td><td>NA</td></tr><tr><td>Other</td><td>CDH, gastrostomy</td><td>no</td><td>abnormal movements and tics</td><td>no</td><td>hearing loss, CMAMMA</td><td>no</td><td>no</td><td>no</td><td>microcytic anemia<xref rid="tblfn11" ref-type="table-fn">f</xref></td><td>no</td><td>PEO, ataxia</td><td>no</td><td>no</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations are as follows: CDH, Congenital dislocation of hip; CMAMMA, combined malonic and methylmalonic aciduria (MIM: <ext-link ext-link-type="omim" xlink:href="614265" id="intref0080">614265</ext-link>) due to <italic>ACSF3</italic> (MIM: <ext-link ext-link-type="omim" xlink:href="614245" id="intref0085">614245</ext-link>) mutations; HCM, hypertrophic cardiomyopathy; NA, not available; and PEO, progressive external ophthalmoplegia.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn6"><label>a</label><p id="ntpara0045">Expressive speech delay only.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn7"><label>b</label><p id="ntpara0050">All individuals are younger than 15 years old; in Bloom syndrome, neoplasia typically manifests in early adulthood.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn8"><label>c</label><p id="ntpara0055">Recurrent otitis media and tonsillitis, leading to tonsillectomy.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn9"><label>d</label><p id="ntpara0060">Reccurent upper-respiratory-tract infections and oral thrush.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn10"><label>e</label><p id="ntpara0065">Mild left-ventricle dilatation.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn11"><label>f</label><p id="ntpara0070">Anemia due to beta-thalassemia trait.</p></fn></table-wrap-foot></table-wrap></p>
      </sec>
      <sec id="sec3.3">
        <title>Cardiomyopathy Is Present in Some Individuals with <italic>TOP3A</italic> Mutations</title>
        <p id="p0095">A single individual compound heterozygous for rare <italic>TOP3A</italic> variants has been reported recently with an adult-onset mitochondrial disorder (denoted as MC1 in <xref rid="tbl1" ref-type="table">Table 1</xref>).<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref> Whereas stature was normal (163Â cm) in this adult female, several of the subjects reported here had clinical features that could also be attributable to mitochondrial dysfunction. P3 and P4 (family 2) had an additional diagnosis of dilated cardiomyopathy, which proved fatal in P4 at age 10 years. Another brother in this sibship died as a result of cardiomyopathy at the age of 13 years. Morphometric and other clinical information are not available for this individual. In P5 (family 3), a dilated cardiomyopathy was also reported, and skeletal muscle biopsy demonstrated 87% mitochondrial DNA depletion. P8 also had asymptomatic left ventricular dilatation noted on echocardiography, whereas P9 had hypertrophic cardiomyopathy.</p>
        <p id="p0100">Given the identification of multiple individuals with biallelic deleterious variants in <italic>TOP3A</italic>, alongside a consistent clinical phenotype across the cohort, we concluded that these mutations were likely to be pathogenic. We therefore pursued confirmatory functional studies by employing both biochemical and cell-biological approaches.</p>
      </sec>
      <sec id="sec3.4">
        <title><italic>TOP3A</italic> Mutations Lead to Markedly Reduced Cellular Amounts of Enzyme TopIIIÎ±</title>
        <p id="p0105">Most of the identified <italic>TOP3A</italic> mutations are predicted to prematurely truncate the encoded protein (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>A) and hence are likely to have significant effects on cellular protein amounts. We therefore assessed the amounts of TopIIIÎ± in primary dermal fibroblast cell lines derived from P1, P7, and P8. Immunoblotting demonstrated that the amount of full-length TopIIIÎ± was substantially lower in total cell lysates from all three individuals than in cell lines from unrelated control individuals and parents (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>B).<fig id="fig2"><label>FigureÂ 2</label><caption><p>Mutations in <italic>TOP3A</italic> Markedly Reduce Amounts of TopIIIÎ± but Do Not Affect Its Intrinsic Decatenation Activity</p><p>(A) Schematic of TopIIIÎ± with locations of variants annotated. Colors are as follows: red, TOPRIM domain; purple, TOPA domain; and blue, GRF zinc-finger domain.</p><p>(B) <italic>TOP3A</italic> mutations markedly reduce protein amounts. An immunoblot of a polyacrylamide gel is shown and was generated from total cell lysates from dermal fibroblast lines derived from affected individuals probed with an anti-TopIIIÎ± antibody. siRNA depletion of TOP3A in a fibroblast line from control 2 was used to confirm the specificity of the antibody. C1 and C2 are unrelated control fibroblast lines. TopIIIÎ± antibody was raised against amino acids 652â1,001.</p><p>(C) Recombinant TopIIIÎ±<sup>Thr812LeufsTer101</sup> (denoted TopIIIÎ±<sup>P1</sup>) is less stable than TopIIIÎ±<sup>WT</sup>. An immunoblot of a polyacrylamide gel is shown and was generated from purified TopIIIÎ±<sup>WT</sup> and TopIIIÎ±<sup>P1</sup> proteins probed with an anti-TopIIIÎ± antibody. Protein size markers are 250, 170, 140, 100, and 70Â kDa.</p><p>(D) Schematic depicting the BTRR complex and its role in dHJ dissolution. Homologous sister chromatids are shown in red and blue.</p><p>(E and F) TopIIIÎ±<sup>P1</sup> is proficient for promoting dHJ dissolution with BLM in combination with RMI1 and RMI2. (E) Representative polyacrylamide gel demonstrating the enzyme-concentration dependence of the dHJ dissolution activity of TopIIIÎ±<sup>WT</sup> and mutant (TopIIIÎ±<sup>P1</sup>) TRR complexes with 20Â nM BLM at 37Â°C in 30Â min. TRR was included in reactions at increasing concentrations ranging from 20 pM to 10Â nM. A labeled circular oligonucleotide (lane 1) and dHJ (lane 2) were included as markers. (F) Quantification of the dHJ dissolution reaction shown in (E). The reaction was repeated twice more with very similar results.</p></caption><graphic xlink:href="gr2"/></fig></p>
        <p id="p0110">In most subjects, the frameshift mutations would be expected to result in nonsense-mediated decay of <italic>TOP3A</italic> transcripts, explaining the consequent loss of TopIIIÎ±. However, the homozygous frameshift mutation in P1 (c.2718del [p.Thr907LeufsTer101]) is at the 3â² end of the gene and is not predicted to result in NMD; instead, it would result in a protein with a length similar to that of the WT enzyme. The frameshift did, however, result in abolition of the C-terminal zinc-finger domain, whose precise cellular function remains to be defined. We therefore expressed recombinant TopIIIÎ±<sup>Thr907LeufsTer101</sup> in <italic>E.Â coli</italic> and purified it to homogeneity as a complex with the co-expressed RMI1 and RMI2 in order to characterize it further. Notably, in contrast to the TRR complex containing TopIIIÎ±<sup>WT</sup>, the complex containing TopIIIÎ±<sup>Thr907LeufsTer101</sup> (hereafter referred to as TopIIIÎ±<sup>P1</sup>) exhibited reduced stability during purification; lower yields and increased amounts of degraded products were evident on SDS-PAGE (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>C). Nevertheless, when used in quantities equimolar to those of TopIIIÎ±<sup>WT</sup>, TopIIIÎ±<sup>P1</sup> was proficient in a biochemical assay for dHJ dissolution when combined with other components of the BTRR complex. This indicates that this TopIIIÎ± variant retains a near-normal level of single-stranded DNA (ssDNA) decatenation activity (<xref rid="fig2" ref-type="fig">Figures 2</xref>Dâ2F). Therefore, we concluded that the major consequence of the TopIIIÎ±<sup>P1</sup> variant, like the other truncating variants, is severe depletion of TopIIIÎ± enzymatic activity in cells.</p>
        <p id="p0115">P5 was the only individual we identified to have an amino acid substitution, p.Ala176Val, that was present <italic>in trans</italic> with a frameshift mutation. This amino acid substitution is absent from GnomAD, and <italic>in silico</italic> analyses (MutationTaster, CADD, and SIFT) predict it to be deleterious. It is at a highly conserved residue (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S1</xref>) within the TOPA domain (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>A) and would therefore be expected to be highly deleterious to enzymatic function.</p>
        <p id="p0120">Given the above results and that <italic>Top3a</italic> is a developmentally essential gene in mice,<xref rid="bib34" ref-type="bibr"><sup>34</sup></xref> we conclude that all of the identified mutations result in marked but most likely hypomorphic loss of function of TopIIIÎ± as a result of a reduction in the cellular amount of the protein. Therefore, these mutations would be predicted to severely compromise the decatenation activity of the BTRR complex in dHJ dissolution <italic>inÂ vivo</italic>. To assess this possibility, we next pursued cellular assays to assess SCE frequency.</p>
      </sec>
      <sec id="sec3.5">
        <title>SCEs Are Markedly Elevated in Individuals with <italic>TOP3A</italic> Mutations</title>
        <p id="p0125">dHJ can be processed by two pathways; first, dissolution by the BTRR complex yields non-crossover products only; second, resolution by endonucleases that cleave Holliday junctions generate both non-crossovers and crossover products that are visualized as SCEs (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>A). To determine if dHJ dissolution is impaired in the cells of affected individuals, we assessed the frequency of SCEs. After BrdU incorporation, we performed differential sister chromatid staining on primary fibroblasts and PHA-stimulated peripheral blood leukocytes (<xref rid="fig3" ref-type="fig">Figures 3</xref>B and 3C). Cells from individuals with <italic>TOP3A</italic> mutations had substantially (3- to 6-fold) more SCEs, than cells from control individuals or heterozygous parents (p &lt; 0.0001 for all affected individual cell lines; <xref rid="fig3" ref-type="fig">FigureÂ 3</xref>C). Therefore, excessive crossover recombination was evident in all tested individuals with <italic>TOP3A</italic> mutations, indicating that diagnostic cytogenetic assessment of SCE levels is predictive of <italic>TOP3A</italic> mutations as well as <italic>BLM</italic> mutations.<fig id="fig3"><label>FigureÂ 3</label><caption><p>Individuals with <italic>TOP3A</italic> Mutations Have More SCEs, Reflecting Chromatid Hyper-recombination</p><p>(A) Schematic of dHJ processing. dHJs are either dissolved by the BTRR complex or alternatively cleaved by structure-specific nucleases that lead to dHJ resolution.</p><p>(B and C) BrdU strand-specific labeling of sister chromatids shows that TOP3A cells have more SCEs than control and parent cells. (B)Â Representative images of P1 and parent fibroblast cell lines. (C)Â Quantification of SCEs in fibroblast cell lines (P1, P5, P7, and P8) or PHA-stimulated lymphocytes derived from peripheral-blood samples (P2 and P3). The median value was plotted with more than ten metaphase spreads counted per subject. Pairwise non-parametric Mann Whitney tests were performed against parental control cells. F1, F2, and F5 SCEs were scored in independent laboratories.</p></caption><graphic xlink:href="gr3"/></fig></p>
      </sec>
      <sec id="sec3.6">
        <title>Chromosome Segregation Defects and Genome Instability Occur in Cells with <italic>TOP3A</italic> Mutations</title>
        <p id="p0130">Impaired dHJ decatenation can result in persistently entangled sister chromatids that impede chromosome segregation at mitosis.<xref rid="bib19" ref-type="bibr"><sup>19</sup></xref> Therefore, we performed detailed characterization of the mitotic consequences of TopIIIÎ± deficiency in primary fibroblasts from P1. DAPI staining demonstrated elevated amounts of chromatin bridges (control [C] = 0, parent = 0.3 Â± 0.4, and P1Â = 4 Â± 0.6) and lagging chromatin and chromosomes (C = 0.9 Â± 0.2, parentÂ = 4 Â± 0.7, and P1Â = 9.2 Â± 0.9) (<xref rid="fig4" ref-type="fig">Figures 4</xref>A and 4B), consistent with persisting chromosome entanglements. Additionally, increased numbers of ultrafine DNA bridges (UFBs) were revealed by immunostaining for PICH on DAPI-negative regions<xref rid="bib19" ref-type="bibr"><sup>19</sup></xref> (C = 2.7 Â± 0.3, parent = 13.1 Â± 1.1, and P1Â = 26.7 Â± 3.8).<fig id="fig4"><label>FigureÂ 4</label><caption><p>DNA Catenanes Persist into Mitosis in Cells with <italic>TOP3A</italic> Mutations, Leading to Chromosome Segregation Defects and Genome Instability</p><p>(A and B) Chromosome segregation is impaired in <italic>TOP3A</italic>-deficient primary fibroblasts. (A) Representative images of chromatin bridges, lagging DNA (DAPI), and UFBs (detected by the presence of PICH and absence of DAPI stain). (B) Quantification of chromatin bridges, lagging DNA, and PICH-positive UFBs scored in control, parental, and P1 mitotic fibroblasts staged at anaphase B (experiments â¥ 3, nÂ &gt;Â 50Â cells, error bars = SEM). To enrich for mitotic cells, we treated fibroblasts with R03306 for 6Â hr and released and fixed them after 45Â min.</p><p>(C) <italic>TOP3A</italic> P1 fibroblasts display significantly elevated amounts of micronuclei. Top: representative picture of control and P1 fibroblasts. Bottom: quantification of micronucleus containing interphase cells (experiments â¥ 3, n &gt; 500, error bars = SEM). To enrich for G1 cells, we released RO3306-treated cells into fresh media for 30Â min and collected, re-seeded, and fixed prometaphase cells after 4â6Â hr.</p><p>(D) P1 fibroblasts with <italic>TOP3A</italic> mutations display significantly elevated numbers of 53BP1 bodies in G1 nuclei. Top: representative images of 53BP1 foci (red) and DNA (DAPI). Bottom: quantification of cells with at least four 53BP1 foci in G1 nuclei (negative for cyclin A) (experiments â¥ 3, n &gt; 500, error bars = SEM). Scale bar: 2 microns. Two-tailed t test was performed against parent cells.</p></caption><graphic xlink:href="gr4"/></fig></p>
        <p id="p0135">We then examined the post-mitotic consequences of the observed chromosome segregation errors by enriching for G1 cells (<xref rid="fig4" ref-type="fig">Figures 4</xref>C and 4D). Micronuclei often arise from chromosome segregation errors,<xref rid="bib35" ref-type="bibr"><sup>35</sup></xref> and analysis of DAPI-stained cells demonstrated substantially more micronucleated cells in the P1 fibroblast cell line than in control and parental cell lines (C = 0.4 Â± 0.2, parent = 1.8 Â± 0.5, and P1Â = 7.5 Â± 1.4). Elevated amounts of 53BP1 nuclear bodies were also seen in cyclin-A-negative (G1) cells, indicating the transmission of DNA damage from one cell cycle to the next<xref rid="bib36" ref-type="bibr"><sup>36</sup></xref> (C = 0.8 Â± 0.3, parent = 4.5 Â± 0.5, and P1Â = 11 Â± 1.7). Altogether, we conclude that impaired dHJ decatenation in TopIIIÎ±-deficient cells results in both abnormal recombination and mitotic errors that lead to accumulation of DNA damage. Because chromatin bridges and UFBs are also present in individuals affected by Bloom syndrome,<xref rid="bib19" ref-type="bibr"><sup>19</sup></xref> these findings are concordant with a shared disease mechanism.</p>
      </sec>
      <sec id="sec3.7">
        <title>A Homozygous Truncating Variant in <italic>RMI1</italic> Is Associated with Microcephalic Dwarfism</title>
        <p id="p0140">Finally, through WES we also identified the homozygous truncating variant c.1255_1259del (p.Lys419Leufs<sup>â</sup>5) in <italic>RMI1</italic> in two affected cousins (P11 and P12) from a consanguineous Turkish family (F8; <xref rid="tbl1" ref-type="table">Table 1</xref> and <xref rid="mmc1" ref-type="supplementary-material">FigureÂ S3</xref>). Both individuals also had microcephalic dwarfism with a clinical phenotype and level of growth restriction similar to those of individuals with <italic>TOP3A</italic> mutations (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>A and <xref rid="tbl2" ref-type="table">Tables 2</xref> and <xref rid="tbl3" ref-type="table">3</xref>).</p>
      </sec>
    </sec>
    <sec id="sec4">
      <title>Discussion</title>
      <p id="p0145">Here, we report that biallelic mutations in <italic>TOP3A</italic> cause prenatal growth restriction, microcephaly, and short stature, a clinical phenotype overlapping that seen in Bloom syndrome. Furthermore, we have identified a rare <italic>RMI1</italic> truncating variant (allele frequency = 1.1Â Ã 10<sup>â5</sup>) in two individuals. Given that no homozygous loss-of-function variants are reported in gnomAD, we expect this to be the cause of microcephalic dwarfism in individuals P11 and P12. However, it will be necessary to identify more individuals with other deleterious sequence variants to establish <italic>RMI1</italic> as a disease-related gene.</p>
      <p id="p0150">Notably, individuals with <italic>TOP3A</italic> mutations exhibit elevated amounts of SCEs on cytogenetic testing. Although cell lines were not available from P11 and P12, we also predict that increased SCEs will occur in cells with the homozygous RMI1 p.Lys419Leufs<sup>â</sup>5 variant given the important role of this protein in the BTRR complex.<xref rid="bib9" ref-type="bibr">9</xref>, <xref rid="bib10" ref-type="bibr">10</xref>, <xref rid="bib37" ref-type="bibr">37</xref> For many years, the diagnosis of Bloom syndrome rested on a demonstration of elevated SCEs, and this has continued to be employed in cases where molecular testing is inconclusive (see GeneReviews in <xref rid="app3" ref-type="sec">Web Resources</xref>). Hence, analysis of other BTRR components is now warranted when elevated SCEs are detected. Indeed, given the clear phenotypic overlap between Bloom syndrome and individuals with <italic>TOP3A</italic> mutations, re-evaluation of individuals previously cytogenetically diagnosed with Bloom syndrome could be fruitful.</p>
      <p id="p0155">RMI2 is the fourth component of the BTRR complex. A single family in which two children were also found to have elevated SCEs was recently reported to have a homozygous deletion of <italic>RMI2</italic>; cafÃ©-au lait macules were evident, but only one individual showed mild-growth impairment.<xref rid="bib38" ref-type="bibr"><sup>38</sup></xref> Because RMI2 is not essential for BTR (BLM, TopIIIÎ±, and RMI1) enzymatic function,<xref rid="bib12" ref-type="bibr"><sup>12</sup></xref> a more subtle cellular and developmental phenotype might therefore result. It also remains possible that the BTR complex has functions independent of RMI2 given that BLM, TopIIIÎ±, and RMI1 are conserved in all eukaryotes but RMI2 is absent in invertebrates and yeast.<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref></p>
      <p id="p0160">Bloom syndrome is associated with a predisposition to both solid tumors and hematological malignancies.<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> However, cancers have not been reported in our individuals with <italic>TOP3A</italic> mutations. Nevertheless, all are stillÂ children, and because malignancy in Bloom syndrome typically manifests in early adulthood, <italic>TOP3A</italic> mutations could also confer an increased risk of neoplasia.</p>
      <p id="p0165">Distinct from Bloom syndrome, some of our individuals with <italic>TOP3A</italic> mutations have clinical features consistent with mitochondrial dysfunction, and several exhibit a dilated cardiomyopathy. Notably, an individual with chronic progressive external ophthalmoplegia and cerebellar ataxia, along with a novel functional role for TopIIIÎ± in the decatenation of mitochondrial DNA after its replication, has been recently reported<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref> (denoted as subject MC1). The compound-heterozygous mutations c.[298A&gt;G];[403C&gt;T], p.[Met100Val];[Arg135<sup>â</sup>] could have milder consequences than those reported in our cohort, and consistent with this, we found that MC1 does not exhibit short stature (<xref rid="tbl2" ref-type="table">Table 2</xref>) or elevated numbers of SCEs in a primary fibroblast line derived from this individual (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S2</xref>). Thus, it appears that the residual TopIIIÎ± activity in MC1 is sufficient for the nuclear function of the BTRR complex in dHJ dissolution and for normal growth but could have become rate limiting for the role of TopIIIÎ± in mitochondrial DNA replication.</p>
      <p id="p0170">Mechanistically, our cellular and biochemical studies suggest that the identified <italic>TOP3A</italic> mutations reported here are severe hypomorphs, consistent with the established essential cellular and developmental functions ofÂ TopIIIÎ±.<xref rid="bib34" ref-type="bibr"><sup>34</sup></xref> Given that marked growth restriction isÂ common in individuals with <italic>TOP3A</italic> and <italic>BLM</italic> mutations, it seems likely that they have a shared pathogenic basis arising from reduced ssDNA decatenation activity of the BTRR complex. Persistence of unresolved hemicatenanes into mitosis leads to the formation of chromatin and ultrafine mitotic bridges that have previously been reported in Bloom syndrome<xref rid="bib19" ref-type="bibr"><sup>19</sup></xref> and in individuals with microcephalic dwarfism and condensin mutations.<xref rid="bib39" ref-type="bibr"><sup>39</sup></xref> The resulting genome instability arising from persistent chromatin bridges<xref rid="bib40" ref-type="bibr">40</xref>, <xref rid="bib41" ref-type="bibr">41</xref> and micronuclei<xref rid="bib42" ref-type="bibr"><sup>42</sup></xref> could therefore impair cell viability during development, causing microcephaly and global growth restriction. InÂ summary, we demonstrate that mutations in <italic>TOP3A</italic> cause microcephalic dwarfism with increased SCE, implicating the BTRR complex as a cause of growth disorders.</p>
    </sec>
    <sec id="sec5">
      <title>Declaration of Interests</title>
      <p id="p0175">M.C. and A.B. are employees of GeneDx Inc., a wholly owned subsidiary of OPKO Health Inc.</p>
    </sec>
  </body>
  <back>
    <ref-list id="cebib0010">
      <title>References</title>
      <ref id="bib1">
        <label>1</label>
        <element-citation publication-type="journal" id="sref1">
          <person-group person-group-type="author">
            <name>
              <surname>Klingseisen</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Jackson</surname>
              <given-names>A.P.</given-names>
            </name>
          </person-group>
          <article-title>Mechanisms and pathways of growth failure in primordial dwarfism</article-title>
          <source>Genes Dev.</source>
          <volume>25</volume>
          <year>2011</year>
          <fpage>2011</fpage>
          <lpage>2024</lpage>
          <pub-id pub-id-type="pmid">21979914</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <label>2</label>
        <element-citation publication-type="journal" id="sref2">
          <person-group person-group-type="author">
            <name>
              <surname>Bloom</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Congenital telangiectatic erythema resembling lupus erythematosus in dwarfs; probably a syndrome entity</article-title>
          <source>AMA Am. J. Dis. Child.</source>
          <volume>88</volume>
          <year>1954</year>
          <fpage>754</fpage>
          <lpage>758</lpage>
          <pub-id pub-id-type="pmid">13206391</pub-id>
        </element-citation>
      </ref>
      <ref id="bib3">
        <label>3</label>
        <element-citation publication-type="journal" id="sref3">
          <person-group person-group-type="author">
            <name>
              <surname>German</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Bloomâs syndrome. XX. The first 100 cancers</article-title>
          <source>Cancer Genet. Cytogenet.</source>
          <volume>93</volume>
          <year>1997</year>
          <fpage>100</fpage>
          <lpage>106</lpage>
          <pub-id pub-id-type="pmid">9062585</pub-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <label>4</label>
        <element-citation publication-type="journal" id="sref4">
          <person-group person-group-type="author">
            <name>
              <surname>Chaganti</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>Schonberg</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>German</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>A manyfold increase in sister chromatid exchanges in Bloomâs syndrome lymphocytes</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>71</volume>
          <year>1974</year>
          <fpage>4508</fpage>
          <lpage>4512</lpage>
          <pub-id pub-id-type="pmid">4140506</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <label>5</label>
        <element-citation publication-type="journal" id="sref5">
          <person-group person-group-type="author">
            <name>
              <surname>Ellis</surname>
              <given-names>N.A.</given-names>
            </name>
            <name>
              <surname>Groden</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Ye</surname>
              <given-names>T.Z.</given-names>
            </name>
            <name>
              <surname>Straughen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Lennon</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Ciocci</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Proytcheva</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>German</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>The Bloomâs syndrome gene product is homologous to RecQ helicases</article-title>
          <source>Cell</source>
          <volume>83</volume>
          <year>1995</year>
          <fpage>655</fpage>
          <lpage>666</lpage>
          <pub-id pub-id-type="pmid">7585968</pub-id>
        </element-citation>
      </ref>
      <ref id="bib6">
        <label>6</label>
        <element-citation publication-type="journal" id="sref6">
          <person-group person-group-type="author">
            <name>
              <surname>German</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Sanz</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Ciocci</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ye</surname>
              <given-names>T.Z.</given-names>
            </name>
            <name>
              <surname>Ellis</surname>
              <given-names>N.A.</given-names>
            </name>
          </person-group>
          <article-title>Syndrome-causing mutations of the BLM gene in persons in the Bloomâs Syndrome Registry</article-title>
          <source>Hum. Mutat.</source>
          <volume>28</volume>
          <year>2007</year>
          <fpage>743</fpage>
          <lpage>753</lpage>
          <pub-id pub-id-type="pmid">17407155</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <label>7</label>
        <element-citation publication-type="journal" id="sref7">
          <person-group person-group-type="author">
            <name>
              <surname>Johnson</surname>
              <given-names>F.B.</given-names>
            </name>
            <name>
              <surname>Lombard</surname>
              <given-names>D.B.</given-names>
            </name>
            <name>
              <surname>Neff</surname>
              <given-names>N.F.</given-names>
            </name>
            <name>
              <surname>Mastrangelo</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Dewolf</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Ellis</surname>
              <given-names>N.A.</given-names>
            </name>
            <name>
              <surname>Marciniak</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Jaenisch</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Guarente</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Association of the Bloom syndrome protein with topoisomerase IIIalpha in somatic and meiotic cells</article-title>
          <source>Cancer Res.</source>
          <volume>60</volume>
          <year>2000</year>
          <fpage>1162</fpage>
          <lpage>1167</lpage>
          <pub-id pub-id-type="pmid">10728666</pub-id>
        </element-citation>
      </ref>
      <ref id="bib8">
        <label>8</label>
        <element-citation publication-type="journal" id="sref8">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Davies</surname>
              <given-names>S.L.</given-names>
            </name>
            <name>
              <surname>North</surname>
              <given-names>P.S.</given-names>
            </name>
            <name>
              <surname>Goulaouic</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Riou</surname>
              <given-names>J.F.</given-names>
            </name>
            <name>
              <surname>Turley</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Gatter</surname>
              <given-names>K.C.</given-names>
            </name>
            <name>
              <surname>Hickson</surname>
              <given-names>I.D.</given-names>
            </name>
          </person-group>
          <article-title>The Bloomâs syndrome gene product interacts with topoisomerase III</article-title>
          <source>J.Â Biol. Chem.</source>
          <volume>275</volume>
          <year>2000</year>
          <fpage>9636</fpage>
          <lpage>9644</lpage>
          <pub-id pub-id-type="pmid">10734115</pub-id>
        </element-citation>
      </ref>
      <ref id="bib9">
        <label>9</label>
        <element-citation publication-type="journal" id="sref9">
          <person-group person-group-type="author">
            <name>
              <surname>Raynard</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Bussen</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Sung</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>A double Holliday junction dissolvasome comprising BLM, topoisomerase IIIalpha, and BLAP75</article-title>
          <source>J.Â Biol. Chem.</source>
          <volume>281</volume>
          <year>2006</year>
          <fpage>13861</fpage>
          <lpage>13864</lpage>
          <pub-id pub-id-type="pmid">16595695</pub-id>
        </element-citation>
      </ref>
      <ref id="bib10">
        <label>10</label>
        <element-citation publication-type="journal" id="sref10">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Bachrati</surname>
              <given-names>C.Z.</given-names>
            </name>
            <name>
              <surname>Ou</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>G.W.</given-names>
            </name>
            <name>
              <surname>Hickson</surname>
              <given-names>I.D.</given-names>
            </name>
          </person-group>
          <article-title>BLAP75/RMI1 promotes the BLM-dependent dissolution of homologous recombination intermediates</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>103</volume>
          <year>2006</year>
          <fpage>4068</fpage>
          <lpage>4073</lpage>
          <pub-id pub-id-type="pmid">16537486</pub-id>
        </element-citation>
      </ref>
      <ref id="bib11">
        <label>11</label>
        <element-citation publication-type="journal" id="sref11">
          <person-group person-group-type="author">
            <name>
              <surname>Yin</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Sobeck</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Meetei</surname>
              <given-names>A.R.</given-names>
            </name>
            <name>
              <surname>Hoatlin</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>BLAP75, an essential component of Bloomâs syndrome protein complexes that maintain genome integrity</article-title>
          <source>EMBO J.</source>
          <volume>24</volume>
          <year>2005</year>
          <fpage>1465</fpage>
          <lpage>1476</lpage>
          <pub-id pub-id-type="pmid">15775963</pub-id>
        </element-citation>
      </ref>
      <ref id="bib12">
        <label>12</label>
        <element-citation publication-type="journal" id="sref12">
          <person-group person-group-type="author">
            <name>
              <surname>Singh</surname>
              <given-names>T.R.</given-names>
            </name>
            <name>
              <surname>Ali</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Busygina</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Raynard</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Du</surname>
              <given-names>C.H.</given-names>
            </name>
            <name>
              <surname>Andreassen</surname>
              <given-names>P.R.</given-names>
            </name>
            <name>
              <surname>Sung</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Meetei</surname>
              <given-names>A.R.</given-names>
            </name>
          </person-group>
          <article-title>BLAP18/RMI2, a novel OB-fold-containing protein, is an essential component of the Bloom helicase-double Holliday junction dissolvasome</article-title>
          <source>Genes Dev.</source>
          <volume>22</volume>
          <year>2008</year>
          <fpage>2856</fpage>
          <lpage>2868</lpage>
          <pub-id pub-id-type="pmid">18923083</pub-id>
        </element-citation>
      </ref>
      <ref id="bib13">
        <label>13</label>
        <element-citation publication-type="journal" id="sref13">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Sobeck</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bachrati</surname>
              <given-names>C.Z.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Enomoto</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>G.W.</given-names>
            </name>
            <name>
              <surname>Hoatlin</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Hickson</surname>
              <given-names>I.D.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>RMI, a new OB-fold complex essential for Bloom syndrome protein to maintain genome stability</article-title>
          <source>Genes Dev.</source>
          <volume>22</volume>
          <year>2008</year>
          <fpage>2843</fpage>
          <lpage>2855</lpage>
          <pub-id pub-id-type="pmid">18923082</pub-id>
        </element-citation>
      </ref>
      <ref id="bib14">
        <label>14</label>
        <element-citation publication-type="journal" id="sref14">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Hickson</surname>
              <given-names>I.D.</given-names>
            </name>
          </person-group>
          <article-title>The Bloomâs syndrome helicase suppresses crossing over during homologous recombination</article-title>
          <source>Nature</source>
          <volume>426</volume>
          <year>2003</year>
          <fpage>870</fpage>
          <lpage>874</lpage>
          <pub-id pub-id-type="pmid">14685245</pub-id>
        </element-citation>
      </ref>
      <ref id="bib15">
        <label>15</label>
        <element-citation publication-type="journal" id="sref15">
          <person-group person-group-type="author">
            <name>
              <surname>Plank</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Hsieh</surname>
              <given-names>T.S.</given-names>
            </name>
          </person-group>
          <article-title>Topoisomerase IIIalpha and Bloomâs helicase can resolve a mobile double Holliday junction substrate through convergent branch migration</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>103</volume>
          <year>2006</year>
          <fpage>11118</fpage>
          <lpage>11123</lpage>
          <pub-id pub-id-type="pmid">16849422</pub-id>
        </element-citation>
      </ref>
      <ref id="bib16">
        <label>16</label>
        <element-citation publication-type="journal" id="sref16">
          <person-group person-group-type="author">
            <name>
              <surname>Wechsler</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Newman</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>West</surname>
              <given-names>S.C.</given-names>
            </name>
          </person-group>
          <article-title>Aberrant chromosome morphology in human cells defective for Holliday junction resolution</article-title>
          <source>Nature</source>
          <volume>471</volume>
          <year>2011</year>
          <fpage>642</fpage>
          <lpage>646</lpage>
          <pub-id pub-id-type="pmid">21399624</pub-id>
        </element-citation>
      </ref>
      <ref id="bib17">
        <label>17</label>
        <element-citation publication-type="journal" id="sref17">
          <person-group person-group-type="author">
            <name>
              <surname>Ajima</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Umezu</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Maki</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Elevated incidence of loss of heterozygosity (LOH) in an sgs1 mutant of Saccharomyces cerevisiae: roles of yeast RecQ helicase in suppression of aneuploidy, interchromosomal rearrangement, and the simultaneous incidence of both events during mitotic growth</article-title>
          <source>Mutat. Res.</source>
          <volume>504</volume>
          <year>2002</year>
          <fpage>157</fpage>
          <lpage>172</lpage>
          <pub-id pub-id-type="pmid">12106656</pub-id>
        </element-citation>
      </ref>
      <ref id="bib18">
        <label>18</label>
        <element-citation publication-type="journal" id="sref18">
          <person-group person-group-type="author">
            <name>
              <surname>Luo</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Santoro</surname>
              <given-names>I.M.</given-names>
            </name>
            <name>
              <surname>McDaniel</surname>
              <given-names>L.D.</given-names>
            </name>
            <name>
              <surname>Nishijima</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Mills</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Youssoufian</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Vogel</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Schultz</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Bradley</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Cancer predisposition caused by elevated mitotic recombination in Bloom mice</article-title>
          <source>Nat. Genet.</source>
          <volume>26</volume>
          <year>2000</year>
          <fpage>424</fpage>
          <lpage>429</lpage>
          <pub-id pub-id-type="pmid">11101838</pub-id>
        </element-citation>
      </ref>
      <ref id="bib19">
        <label>19</label>
        <element-citation publication-type="journal" id="sref19">
          <person-group person-group-type="author">
            <name>
              <surname>Chan</surname>
              <given-names>K.L.</given-names>
            </name>
            <name>
              <surname>North</surname>
              <given-names>P.S.</given-names>
            </name>
            <name>
              <surname>Hickson</surname>
              <given-names>I.D.</given-names>
            </name>
          </person-group>
          <article-title>BLM is required for faithful chromosome segregation and its localization defines a class of ultrafine anaphase bridges</article-title>
          <source>EMBO J.</source>
          <volume>26</volume>
          <year>2007</year>
          <fpage>3397</fpage>
          <lpage>3409</lpage>
          <pub-id pub-id-type="pmid">17599064</pub-id>
        </element-citation>
      </ref>
      <ref id="bib20">
        <label>20</label>
        <element-citation publication-type="journal" id="sref20">
          <person-group person-group-type="author">
            <name>
              <surname>Cole</surname>
              <given-names>T.J.</given-names>
            </name>
            <name>
              <surname>Freeman</surname>
              <given-names>J.V.</given-names>
            </name>
            <name>
              <surname>Preece</surname>
              <given-names>M.A.</given-names>
            </name>
          </person-group>
          <article-title>British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood</article-title>
          <source>Stat. Med.</source>
          <volume>17</volume>
          <year>1998</year>
          <fpage>407</fpage>
          <lpage>429</lpage>
          <pub-id pub-id-type="pmid">9496720</pub-id>
        </element-citation>
      </ref>
      <ref id="bib21">
        <label>21</label>
        <element-citation publication-type="journal" id="sref21">
          <person-group person-group-type="author">
            <name>
              <surname>Keller</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Keller</surname>
              <given-names>K.R.</given-names>
            </name>
            <name>
              <surname>Shew</surname>
              <given-names>S.B.</given-names>
            </name>
            <name>
              <surname>Plon</surname>
              <given-names>S.E.</given-names>
            </name>
          </person-group>
          <article-title>Growth deficiency and malnutrition in Bloom syndrome</article-title>
          <source>J.Â Pediatr.</source>
          <volume>134</volume>
          <year>1999</year>
          <fpage>472</fpage>
          <lpage>479</lpage>
          <pub-id pub-id-type="pmid">10190923</pub-id>
        </element-citation>
      </ref>
      <ref id="bib22">
        <label>22</label>
        <element-citation publication-type="journal" id="sref22">
          <person-group person-group-type="author">
            <name>
              <surname>Murray</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Bicknell</surname>
              <given-names>L.S.</given-names>
            </name>
            <name>
              <surname>Yigit</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Duker</surname>
              <given-names>A.L.</given-names>
            </name>
            <name>
              <surname>van Kogelenberg</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Haghayegh</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Wieczorek</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Kayserili</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Albert</surname>
              <given-names>M.H.</given-names>
            </name>
            <name>
              <surname>Wise</surname>
              <given-names>C.A.</given-names>
            </name>
          </person-group>
          <article-title>Extreme growth failure is a common presentation of ligase IV deficiency</article-title>
          <source>Hum. Mutat.</source>
          <volume>35</volume>
          <year>2014</year>
          <fpage>76</fpage>
          <lpage>85</lpage>
          <pub-id pub-id-type="pmid">24123394</pub-id>
        </element-citation>
      </ref>
      <ref id="bib23">
        <label>23</label>
        <element-citation publication-type="journal" id="sref23">
          <person-group person-group-type="author">
            <name>
              <surname>Tanaka</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>M.T.</given-names>
            </name>
            <name>
              <surname>Millan</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Juusola</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Retterer</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Joshi</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Niyazov</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Garnica</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Gratz</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Deardorff</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Mutations in SPATA5 Are Associated with Microcephaly, Intellectual Disability, Seizures, and Hearing Loss</article-title>
          <source>Am. J. Hum. Genet.</source>
          <volume>97</volume>
          <year>2015</year>
          <fpage>457</fpage>
          <lpage>464</lpage>
          <pub-id pub-id-type="pmid">26299366</pub-id>
        </element-citation>
      </ref>
      <ref id="bib24">
        <label>24</label>
        <element-citation publication-type="journal" id="sref24">
          <person-group person-group-type="author">
            <name>
              <surname>Goulaouic</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Roulon</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Flamand</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Grondard</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Lavelle</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Riou</surname>
              <given-names>J.F.</given-names>
            </name>
          </person-group>
          <article-title>Purification and characterization of human DNA topoisomerase IIIalpha</article-title>
          <source>Nucleic Acids Res.</source>
          <volume>27</volume>
          <year>1999</year>
          <fpage>2443</fpage>
          <lpage>2450</lpage>
          <pub-id pub-id-type="pmid">10352172</pub-id>
        </element-citation>
      </ref>
      <ref id="bib25">
        <label>25</label>
        <element-citation publication-type="journal" id="sref25">
          <person-group person-group-type="author">
            <name>
              <surname>Karow</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>Chakraverty</surname>
              <given-names>R.K.</given-names>
            </name>
            <name>
              <surname>Hickson</surname>
              <given-names>I.D.</given-names>
            </name>
          </person-group>
          <article-title>The Bloomâs syndrome gene product is a 3â²-5â² DNA helicase</article-title>
          <source>J.Â Biol. Chem.</source>
          <volume>272</volume>
          <year>1997</year>
          <fpage>30611</fpage>
          <lpage>30614</lpage>
          <pub-id pub-id-type="pmid">9388193</pub-id>
        </element-citation>
      </ref>
      <ref id="bib26">
        <label>26</label>
        <element-citation publication-type="journal" id="sref26">
          <person-group person-group-type="author">
            <name>
              <surname>Henricksen</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Umbricht</surname>
              <given-names>C.B.</given-names>
            </name>
            <name>
              <surname>Wold</surname>
              <given-names>M.S.</given-names>
            </name>
          </person-group>
          <article-title>Recombinant replication protein A: expression, complex formation, and functional characterization</article-title>
          <source>J.Â Biol. Chem.</source>
          <volume>269</volume>
          <year>1994</year>
          <fpage>11121</fpage>
          <lpage>11132</lpage>
          <pub-id pub-id-type="pmid">8157639</pub-id>
        </element-citation>
      </ref>
      <ref id="bib27">
        <label>27</label>
        <element-citation publication-type="book" id="sref27">
          <person-group person-group-type="editor">
            <name>
              <surname>Rooney</surname>
              <given-names>D.E.</given-names>
            </name>
          </person-group>
          <source>Human cytogenetics: Malignancy and acquired abnormalities</source>
          <edition>Third Edition</edition>
          <year>2001</year>
          <publisher-name>Oxford University Press</publisher-name>
        </element-citation>
      </ref>
      <ref id="bib28">
        <label>28</label>
        <element-citation publication-type="journal" id="sref28">
          <person-group person-group-type="author">
            <name>
              <surname>Bizard</surname>
              <given-names>A.H.</given-names>
            </name>
            <name>
              <surname>Nielsen</surname>
              <given-names>C.F.</given-names>
            </name>
            <name>
              <surname>Hickson</surname>
              <given-names>I.D.</given-names>
            </name>
          </person-group>
          <article-title>Detection of Ultrafine Anaphase Bridges</article-title>
          <source>Methods Mol. Biol.</source>
          <volume>1672</volume>
          <year>2018</year>
          <fpage>495</fpage>
          <lpage>508</lpage>
          <pub-id pub-id-type="pmid">29043644</pub-id>
        </element-citation>
      </ref>
      <ref id="bib29">
        <label>29</label>
        <element-citation publication-type="journal" id="sref29">
          <person-group person-group-type="author">
            <name>
              <surname>Bhowmick</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Minocherhomji</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Hickson</surname>
              <given-names>I.D.</given-names>
            </name>
          </person-group>
          <article-title>RAD52 Facilitates Mitotic DNA Synthesis Following Replication Stress</article-title>
          <source>Mol. Cell</source>
          <volume>64</volume>
          <year>2016</year>
          <fpage>1117</fpage>
          <lpage>1126</lpage>
          <pub-id pub-id-type="pmid">27984745</pub-id>
        </element-citation>
      </ref>
      <ref id="bib30">
        <label>30</label>
        <element-citation publication-type="journal" id="sref30">
          <person-group person-group-type="author">
            <name>
              <surname>Nielsen</surname>
              <given-names>C.F.</given-names>
            </name>
            <name>
              <surname>Huttner</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Bizard</surname>
              <given-names>A.H.</given-names>
            </name>
            <name>
              <surname>Hirano</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>T.N.</given-names>
            </name>
            <name>
              <surname>Palmai-Pallag</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Bjerregaard</surname>
              <given-names>V.A.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Nigg</surname>
              <given-names>E.A.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L.H.</given-names>
            </name>
            <name>
              <surname>Hickson</surname>
              <given-names>I.D.</given-names>
            </name>
          </person-group>
          <article-title>PICH promotes sister chromatid disjunction and co-operates with topoisomerase II in mitosis</article-title>
          <source>Nat. Commun.</source>
          <volume>6</volume>
          <year>2015</year>
          <fpage>8962</fpage>
          <pub-id pub-id-type="pmid">26643143</pub-id>
        </element-citation>
      </ref>
      <ref id="bib31">
        <label>31</label>
        <element-citation publication-type="journal" id="sref31">
          <person-group person-group-type="author">
            <name>
              <surname>Sobreira</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Schiettecatte</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Valle</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Hamosh</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>GeneMatcher: a matching tool for connecting investigators with an interest in the same gene</article-title>
          <source>Hum. Mutat.</source>
          <volume>36</volume>
          <year>2015</year>
          <fpage>928</fpage>
          <lpage>930</lpage>
          <pub-id pub-id-type="pmid">26220891</pub-id>
        </element-citation>
      </ref>
      <ref id="bib32">
        <label>32</label>
        <element-citation publication-type="journal" id="sref32">
          <person-group person-group-type="author">
            <name>
              <surname>Nicholls</surname>
              <given-names>T.J.</given-names>
            </name>
            <name>
              <surname>Nadalutti</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Motori</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Sommerville</surname>
              <given-names>E.W.</given-names>
            </name>
            <name>
              <surname>Gorman</surname>
              <given-names>G.S.</given-names>
            </name>
            <name>
              <surname>Basu</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Hoberg</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Turnbull</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Chinnery</surname>
              <given-names>P.F.</given-names>
            </name>
            <name>
              <surname>Larsson</surname>
              <given-names>N.G.</given-names>
            </name>
          </person-group>
          <article-title>Topoisomerase 3Î± Is Required for Decatenation and Segregation of Human mtDNA</article-title>
          <source>Mol. Cell</source>
          <volume>69</volume>
          <year>2018</year>
          <fpage>9</fpage>
          <lpage>23.e6</lpage>
          <pub-id pub-id-type="pmid">29290614</pub-id>
        </element-citation>
      </ref>
      <ref id="bib33">
        <label>33</label>
        <element-citation publication-type="journal" id="sref33">
          <person-group person-group-type="author">
            <name>
              <surname>Lek</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Karczewski</surname>
              <given-names>K.J.</given-names>
            </name>
            <name>
              <surname>Minikel</surname>
              <given-names>E.V.</given-names>
            </name>
            <name>
              <surname>Samocha</surname>
              <given-names>K.E.</given-names>
            </name>
            <name>
              <surname>Banks</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Fennell</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>OâDonnell-Luria</surname>
              <given-names>A.H.</given-names>
            </name>
            <name>
              <surname>Ware</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Cummings</surname>
              <given-names>B.B.</given-names>
            </name>
            <collab>Exome Aggregation Consortium</collab>
          </person-group>
          <article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>
          <source>Nature</source>
          <volume>536</volume>
          <year>2016</year>
          <fpage>285</fpage>
          <lpage>291</lpage>
          <pub-id pub-id-type="pmid">27535533</pub-id>
        </element-citation>
      </ref>
      <ref id="bib34">
        <label>34</label>
        <element-citation publication-type="journal" id="sref34">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J.C.</given-names>
            </name>
          </person-group>
          <article-title>Mammalian DNA topoisomerase IIIalpha is essential in early embryogenesis</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>95</volume>
          <year>1998</year>
          <fpage>1010</fpage>
          <lpage>1013</lpage>
          <pub-id pub-id-type="pmid">9448276</pub-id>
        </element-citation>
      </ref>
      <ref id="bib35">
        <label>35</label>
        <element-citation publication-type="journal" id="sref35">
          <person-group person-group-type="author">
            <name>
              <surname>Hoffelder</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Burke</surname>
              <given-names>N.A.</given-names>
            </name>
            <name>
              <surname>Watkins</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>Gollin</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Saunders</surname>
              <given-names>W.S.</given-names>
            </name>
          </person-group>
          <article-title>Resolution of anaphase bridges in cancer cells</article-title>
          <source>Chromosoma</source>
          <volume>112</volume>
          <year>2004</year>
          <fpage>389</fpage>
          <lpage>397</lpage>
          <pub-id pub-id-type="pmid">15156327</pub-id>
        </element-citation>
      </ref>
      <ref id="bib36">
        <label>36</label>
        <element-citation publication-type="journal" id="sref36">
          <person-group person-group-type="author">
            <name>
              <surname>Lukas</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Savic</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Bekker-Jensen</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Doil</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Neumann</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Pedersen</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>GrÃ¸fte</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>K.L.</given-names>
            </name>
            <name>
              <surname>Hickson</surname>
              <given-names>I.D.</given-names>
            </name>
            <name>
              <surname>Bartek</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Lukas</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>53BP1 nuclear bodies form around DNA lesions generated by mitotic transmission of chromosomes under replication stress</article-title>
          <source>Nat. Cell Biol.</source>
          <volume>13</volume>
          <year>2011</year>
          <fpage>243</fpage>
          <lpage>253</lpage>
          <pub-id pub-id-type="pmid">21317883</pub-id>
        </element-citation>
      </ref>
      <ref id="bib37">
        <label>37</label>
        <element-citation publication-type="journal" id="sref37">
          <person-group person-group-type="author">
            <name>
              <surname>Bocquet</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Bizard</surname>
              <given-names>A.H.</given-names>
            </name>
            <name>
              <surname>Abdulrahman</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Larsen</surname>
              <given-names>N.B.</given-names>
            </name>
            <name>
              <surname>Faty</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Cavadini</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Bunker</surname>
              <given-names>R.D.</given-names>
            </name>
            <name>
              <surname>Kowalczykowski</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>Cejka</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Hickson</surname>
              <given-names>I.D.</given-names>
            </name>
            <name>
              <surname>ThomÃ¤</surname>
              <given-names>N.H.</given-names>
            </name>
          </person-group>
          <article-title>Structural and mechanistic insight into Holliday-junction dissolution by topoisomerase IIIÎ± and RMI1</article-title>
          <source>Nat. Struct. Mol. Biol.</source>
          <volume>21</volume>
          <year>2014</year>
          <fpage>261</fpage>
          <lpage>268</lpage>
          <pub-id pub-id-type="pmid">24509834</pub-id>
        </element-citation>
      </ref>
      <ref id="bib38">
        <label>38</label>
        <element-citation publication-type="journal" id="sref38">
          <person-group person-group-type="author">
            <name>
              <surname>Hudson</surname>
              <given-names>D.F.</given-names>
            </name>
            <name>
              <surname>Amor</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Boys</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Butler</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kalitsis</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Loss of RMI2 Increases Genome Instability and Causes a Bloom-Like Syndrome</article-title>
          <source>PLoS Genet.</source>
          <volume>12</volume>
          <year>2016</year>
          <fpage>e1006483</fpage>
          <pub-id pub-id-type="pmid">27977684</pub-id>
        </element-citation>
      </ref>
      <ref id="bib39">
        <label>39</label>
        <element-citation publication-type="journal" id="sref39">
          <person-group person-group-type="author">
            <name>
              <surname>Martin</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Carroll</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Leitch</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Mackenzie</surname>
              <given-names>K.J.</given-names>
            </name>
            <name>
              <surname>Halachev</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Fetit</surname>
              <given-names>A.E.</given-names>
            </name>
            <name>
              <surname>Keith</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Bicknell</surname>
              <given-names>L.S.</given-names>
            </name>
            <name>
              <surname>Fluteau</surname>
              <given-names>A.</given-names>
            </name>
            <collab>Deciphering Developmental Disorders Study</collab>
          </person-group>
          <article-title>Mutations in genes encoding condensin complex proteins cause microcephaly through decatenation failure at mitosis</article-title>
          <source>Genes Dev.</source>
          <volume>30</volume>
          <year>2016</year>
          <fpage>2158</fpage>
          <lpage>2172</lpage>
          <pub-id pub-id-type="pmid">27737959</pub-id>
        </element-citation>
      </ref>
      <ref id="bib40">
        <label>40</label>
        <element-citation publication-type="journal" id="sref40">
          <person-group person-group-type="author">
            <name>
              <surname>Janssen</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>van der Burg</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Szuhai</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kops</surname>
              <given-names>G.J.</given-names>
            </name>
            <name>
              <surname>Medema</surname>
              <given-names>R.H.</given-names>
            </name>
          </person-group>
          <article-title>Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations</article-title>
          <source>Science</source>
          <volume>333</volume>
          <year>2011</year>
          <fpage>1895</fpage>
          <lpage>1898</lpage>
          <pub-id pub-id-type="pmid">21960636</pub-id>
        </element-citation>
      </ref>
      <ref id="bib41">
        <label>41</label>
        <element-citation publication-type="journal" id="sref41">
          <person-group person-group-type="author">
            <name>
              <surname>Maciejowski</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Bosco</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>de Lange</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Chromothripsis and Kataegis Induced by Telomere Crisis</article-title>
          <source>Cell</source>
          <volume>163</volume>
          <year>2015</year>
          <fpage>1641</fpage>
          <lpage>1654</lpage>
          <pub-id pub-id-type="pmid">26687355</pub-id>
        </element-citation>
      </ref>
      <ref id="bib42">
        <label>42</label>
        <element-citation publication-type="journal" id="sref42">
          <person-group person-group-type="author">
            <name>
              <surname>Crasta</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Ganem</surname>
              <given-names>N.J.</given-names>
            </name>
            <name>
              <surname>Dagher</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Lantermann</surname>
              <given-names>A.B.</given-names>
            </name>
            <name>
              <surname>Ivanova</surname>
              <given-names>E.V.</given-names>
            </name>
            <name>
              <surname>Pan</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Nezi</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Protopopov</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Chowdhury</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Pellman</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>DNA breaks and chromosome pulverization from errors in mitosis</article-title>
          <source>Nature</source>
          <volume>482</volume>
          <year>2012</year>
          <fpage>53</fpage>
          <lpage>58</lpage>
          <pub-id pub-id-type="pmid">22258507</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec id="app3">
      <title>Web Resources</title>
      <p id="p0195">
        <list list-type="simple" id="ulist0010">
          <list-item id="u0010">
            <p id="p0200">GenBank, <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/genbank/" id="intref0045">https://www.ncbi.nlm.nih.gov/genbank/</ext-link></p>
          </list-item>
          <list-item id="u0015">
            <p id="p0205">GeneReviews, Sanz, M.M., German, J., and Cunniff, C. (1993). Bloomâs Syndrome, <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK1398/" id="intref0050">https://www.ncbi.nlm.nih.gov/books/NBK1398/</ext-link></p>
          </list-item>
          <list-item id="u0020">
            <p id="p0210">GnomAD, <ext-link ext-link-type="uri" xlink:href="http://gnomad.broadinstitute.org" id="intref0055">http://gnomad.broadinstitute.org</ext-link></p>
          </list-item>
          <list-item id="u0025">
            <p id="p0215">OMIM, <ext-link ext-link-type="uri" xlink:href="http://www.omim.org" id="intref0060">http://www.omim.org</ext-link></p>
          </list-item>
        </list>
      </p>
    </sec>
    <sec id="app2" sec-type="supplementary-material">
      <title>Supplemental Data</title>
      <p id="p0190">
        <supplementary-material content-type="local-data" id="mmc1">
          <caption>
            <title>Document S1. Figures S1âS3 and Table S1</title>
          </caption>
          <media xlink:href="mmc1.pdf"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="mmc2">
          <caption>
            <title>Document S2. Article plus Supplemental Data</title>
          </caption>
          <media xlink:href="mmc2.pdf"/>
        </supplementary-material>
      </p>
    </sec>
    <ack id="ack0010">
      <title>Acknowledgments</title>
      <p>We thank the families and clinicians for their participation, the Potentials Foundation and Walking with Giants Foundation, the Medical Research Council (MRC) Institute of Genetics &amp; Molecular Medicine core sequencing service, and G. Stewart and D. Fitzpatrick for helpful discussions. This work was supported by funding from <funding-source id="gs1">European Research Council</funding-source> 281847; <funding-source id="gs2">MRC Human Genetics Unit</funding-source>Â U127580972; and <funding-source id="gs3">Danish National Research Foundation</funding-source> DNRF115 (I.D.H.); a <funding-source id="gs4">Danish Cancer Society</funding-source> postdoctoral fellowship (A10769 to R.S.T.); <funding-source id="gs5">Ministerio de EconomÃ­a y Competitividad (MINECO)</funding-source> SAF2015-66831-R and SAF2017-84646-R (K.E.H.); the <funding-source id="gs6">InstituciÃ³ Catalana de Recerca i Estudis AvanÃ§ats</funding-source> Academia program, <funding-source id="gs7">MINECO</funding-source> SAF2015-64152-R, the <funding-source id="gs8">European Commission</funding-source>, the <funding-source id="gs9">Fondo Europeo de Desarrollo Regional âUna Manera de Hacer Europa</funding-source>,â and the <funding-source id="gs10">Centro de InvestigaciÃ³n BiomÃ©dica en Red de Enfermedades Raras</funding-source>, an initiative of the Instituto de Salud CarlosÂ III (J.S.); <funding-source id="gs11">Wellcome Centre for Mitochondrial Research</funding-source> 203105/Z/16/Z, <funding-source id="gs12">MRC</funding-source> G0601943 and G0800674, and <funding-source id="gs13">National Health Service</funding-source> Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children (R.W.T. and G.S.G.); <funding-source id="gs14">German Federal Ministry of Education and Research</funding-source> 01GM1404, <funding-source id="gs15">E-Rare network EuroMicro</funding-source> (01GM1404), and <funding-source id="gs16">German Research Foundation</funding-source> SFB1002 project D02 (B.W.); theÂ Practical Research Project for Rare/Intractable Diseases (18ek0109273 and 18ek0109177) from the <funding-source id="gs17">Japan Agency for Medical Research and Development</funding-source> (K.M, A.O, and Y.O); the <funding-source id="gs18">Great Ormond Street Hospital Childrenâs Charity</funding-source> and <funding-source id="gs19">NIHR Great Ormond Street Hospital Biomedical Research Centre</funding-source> (M.T.D.); and <funding-source id="gs20">NIH National Center for Advancing Translational Sciences</funding-source> UL1TR001873 (A.R.P. and A.I.). The content and views expressed are solely the responsibility of the authors and not necessarily those of the NIH, NIHR, or Department of Health.</p>
    </ack>
    <fn-group>
      <fn id="app1" fn-type="supplementary-material">
        <p id="p0185">Supplemental Data include three figures and one table and can be found with this article online at <ext-link ext-link-type="doi" xlink:href="10.1016/j.ajhg.2018.07.001" id="intref0040">https://doi.org/10.1016/j.ajhg.2018.07.001</ext-link>.</p>
      </fn>
    </fn-group>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>